Displaying 1 to 19 of 19 investments
Country Date Notes
Ablynx NV
 Belgium 31 Dec 2004 Other
Active
Akubio Ltd
Provider of acoustic detection systems for real time analysis of biomolecular behavior 		United States 31 Dec 2007 N/A
Active
Alexza Pharmaceuticals Inc
 United States 31 Dec 2005 N/A
Active
Broncus Technologies Inc
Developer of interventional bronchoscopy devices for the treatment of chronic lung diseases. 		United States 31 Dec 2006 N/A
Active
Dynogen Pharmaceuticals Inc
Drug company focused on gastrointestinal and genitourinary disorders. 		United States 31 Dec 2004 N/A
Active
Fovea Pharmaceuticals
 France 31 Dec 2005 N/A
Active
Gynesonics
 United States 31 Dec 2005 N/A
Active
Healthcare Brands Intl Ltd
Committed to translating innovative science into meaningful consumer brands. Sold subsidiary, Antula Healthcare, for SEK 1.8bn in April 2011. 		United Kingdom N/A
Intelligent Medical Implants
 Germany 31 Dec 2006 N/A
Active
Magellan
 United States 31 Dec 2006 N/A
Active
Novexel
 France 31 Dec 2004 N/A
Active
Portola Pharmaceuticals Inc
 United States 31 Dec 2003 N/A
Active
Powder Med
 United Kingdom 31 Dec 2004 N/A
Active
Prosensa
 Netherlands 31 Dec 2006 N/A
Active
Supernus Pharmaceuticals Inc
 United States 31 Dec 2006 N/A
Active
Synosia Therapeutics
Develops innovative treatments for disorders of the central nervous system 		United States 31 Dec 2005 N/A
Active
Syntaxin Ltd
 United Kingdom 31 Dec 2005 N/A
Active
Zogenix Inc
A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. 		United States 31 Dec 2007 N/A
Active
Zogenix Inc
A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. 		United States 1 Sep 2009 Series B
Initial investment. Round participant. Active